Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells
Open Access
- 9 September 2004
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 18 (10) , 1599-1604
- https://doi.org/10.1038/sj.leu.2403469
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Farnesyl transferase inhibitors in clinical developmentExpert Opinion on Investigational Drugs, 2003
- Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemiaLeukemia, 2002
- A Systematic Overview of Chemotherapy Effects in B-cell Chronic Lymphocytic LeukaemiaActa Oncologica, 2001
- Chronic Lymphocytic Leukemia: Case-Based SessionHematology-American Society Hematology Education Program, 2001
- Design of growth factor antagonists with antiangiogenic and antitumor propertiesOncogene, 2000
- Chronic lymphocytic leukemiaCurrent Opinion in Hematology, 2000
- The National Cancer Data Base Report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemiaCancer, 1999
- Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations With In Vitro and In Vivo ChemoresponsesBlood, 1998
- A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: Mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphomaInternational Journal of Cancer, 1997
- Absence of kirsten-ras oncogene activation in B-cell chronic lymphocytic leukemiaLeukemia Research, 1988